Patient-specific internal radionuclide dosimetry

Nuclear Medicine Communications

Volumn 31, Issue 2, 2010, Pages 97-106

  Tsougos, Ioannis ^a   Loudos, George ^c   Georgoulias, Panagiotis ^b   Theodorou, Kiki ^a   Kappas, Constantin ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

Absorbed dose; Dosimetry; Monte Carlo; Nuclear medicine; Radionuclide therapy; Tomographic data; Treatment planning

Indexed keywords

RADIOISOTOPE;

COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DOSIMETRY; HUMAN; KERNEL METHOD; MEDICAL INFORMATION; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; REVIEW; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

HUMANS; IMAGING, THREE-DIMENSIONAL; INDIVIDUALIZED MEDICINE; PHANTOMS, IMAGING; RADIOISOTOPES; RADIOMETRY; SOFTWARE;

EID: 75149116261     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328330626f     Document Type: Review

References (53)

1. Sgouros G. Dosimetry of internal emitters. J Nucl Med 2005; 46 (Suppl 1): 18S-27S.
2. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005; 46:1023-1027.
3. Loevinger R, Budinger T, Watson E. MIRD primer for absorbed dose calculations. New York: Society of Nuclear Medicine; 1988.
4. Snyder WS, Ford MR,Warner GG. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamplet No. 5, rev. New York, NY: Society of Nuclear Medicine; 1978.
5. Snyder WS, Fisher HL, Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J NuclMed 1969; 10 (Suppl):7S-52S.
6. Cristy M, Eckerman K. Specific absorbd fractions of energy at various ages from internal photon sources ORNL/TM-8381V1-V7. Oak Ridge, TN: Oak Ridge National Laboratory; 1987.
7. Stabin MG, Flux GD. Internal dosimetry as a tool for radiation protection of the patient in nuclear medicine. Biomed Imaging Interv J 2007; 3:e28.
8. Stabin M. MIRDOSE - the personal computer software for use in internal dose assessment in nuclear medicine. J Nucl Med 1996; 37:538-546.
9. Eckerman KF, Cristy M,Warner GG. Dosimetric evaluation of brain scanning agents. In: Watson EE, Schlafke-Stelson AT, Coffey JL, Cloutier RJ, editors. Radiopharmaceutical dosimetry symptoms. Rockville, Maryland: HHS Publication FDA; 1981. pp. 81-86.
10. Holman BL, Zimmerman RL, Shapiro JR, Kaplan ML, Jones AG, Hill TC. Biodistribution and dosimetry of n-isoproyl p-123I iodoamphetamine in the primate. J Nucl Med 1983; 24:922-931.
11. Bouchet LG, Jokisch DW, Bolch WE. A three-dimensional transport model for determining absorbed fractions of energy for electrons within trabecular bone. J Nucl Med 1999; 40:1947-1966.
12. Watson EW, Stabin MG. BASIC alternative software package for internal dose calculations. Computer Applications in Health Physics: Proceedings of 17th Midyear Topical Symposium of the Health Physics Society (Pasco,WA, 5-9 February) 1984. pp. 7.79-7.86.
13. Stabin MG. A model of the prostate gland for use in internal dosimetry. J Nucl Med 1994; 35:516-520.
14. Eckerman K, Stabin M. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. Health Phys 2000; 78:199-214.
15. Stabin MG, Konijnenberg MR. E-evaluation of absorbed fractions for photons and electrons in small spheres. J Nucl Med 2000; 41:149-160.
16. Johnson TK, McClure D, McCourt S. MABDOSE. I: characterization of a general purpose dose estimation code. Med Phys 1999; 26:1389-1395. (Pubitemid 29334809)
17. Flux G, Bardies M, Monsieurs M, Savolainen S, Strand SE, Lassmann M. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. Z Med Phys 2006; 16:47-59.
18. Siegel JA, Stabin MG, Brill AB. The importance of patients-pecific radiation dose calculations for the administration of radionuclides in therapy. Cell Mol Biol 2002; 48:451-459.
19. Stabin MG, Konijnenberg M, Knapp FF Jr, Spencer RH. Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy. Med Phys 2000; 27:1086-1092.
20. Cremonesi M, Ferrari M, Bodei L, Tosi G, Paganelli G. Dosimetry in peptide radionuclide receptor therapy: a review. J Nucl Med 2006; 47:1467-1475.
21. Bardies M, Flux G, Lassmann M, Monsieurs M, Savolainen S, Strand SE. Quantitative imaging for clinical dosimetry. Nuclear Instruments and Methods in Physics Research A 2006; 569:467-471.
22. Pauwels S, Barone R, Walrand S. Practical dosimetry of peptide receptor radionuclide therapy with 90Y-labeled somatostatin analogs. J Nucl Med 2005; 46 (Suppl 1):92S-98S. (Pubitemid 47619024)
23. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999; 40:37S-61S.
24. Kolbert KS, Sgouros G, Scott AM, Bronstein JE, Malane RA, Zhang J, et al. Implementation and evaluation of patient-specific three-dimensional internal dosimetry. J Nucl Med 1997; 38:301-308. (Pubitemid 27061616)
25. Liu A, Williams L, Lopatin G, Yamauchi D, Wong J, Raubitschek A. A radionuclide therapy treatment planning and dose estimation system. J Nucl Med 1999; 40:1151-1153.
26. Clairand I, Ricard M, Gouriou J, Di Paola M, Aubert B. DOSE3D: EGS4 Monte Carlo code-based software for internal radionuclide dosimetry. J Nucl Med 1999; 40:1517-1523.
27. Dewaraja YK,Wilderman SJ, Ljungberg M, Koral KF, Kenneth Z, Kaminiski MS. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation. J Nucl Med 2005; 46:840-849.
28. Sgouros G, Barest G, Thekkumthala J. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med 1990; 31:1884-1891.
29. Sgouros G, Chiu S, Pentlow KS. Three-dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med 1993; 34:1595-1601.
30. Sgouros G, Squeri S, Ballangrud AM. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. J Nucl Med 2003; 44:260-268.
31. Sgouros G, Kolbert KS, Sheikh A. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004; 45:1366-1372.
32. Koral KF, Francis IR, Kroll S. Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method. Cancer 2002; 94:1258-1263.
33. Nelson WR, Hirayama H, Rogers DW. The EGS4 code system. SLAC Report No.265 (SLAC, Stanford, CA, 1985).
34. Agostinelli S. Geant4-a simulation toolkit. Nuclear Instrum Methods Phys Res A 2003; 506:250-303.
35. Briesmeister JF. 2000 Report LA-13709-M, Los Alamos National Laboratory, NM.
36. Ljungberg M, Strand SE. Comput. Methods Prog Biomed 1989; 2:257-272.
37. Chen CL, Wang Y, Lee JJ, Tsui BM. Integration of SimSET photon history generator in GATE for efficient Monte Carlo simulations of pinhole SPECT. Med Phys 2008; 35:3278-3284.
38. Jan S, Santin G, Strul D, Staelens S, Assié K, Autret D, et al. GATE: a simulation toolkit for PET and SPECT. Phys Med Biol 2004; 49:4543-4561.
39. Difilippo F, Papiez L, Moskvin V, Peplow D, DesRosiers C, Johnson J, et al. Contamination dose from photoneutron processes in bodily tissues during therapeutic radiation delivery. Med Phys 2003; 30:2849-2854.
40. Zaidi H, Hasegawa B. Determination of the attenuation map in emission tomography. J Nucl Med 2003; 44:291-315.
41. Watson CC, Casey ME, Bendriem B, Carney JP, Townsend DW, Eberl S, et al. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. J Nucl Med 2005; 46:1825-1834.
42. Osman MM, Cohade C, Nakamoto Y,Wahl RL. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging 2003; 30:603-606.
43. Furhang EE, Sgouros G, Chui CS. Radionuclide photon dose kernels for internal emitter dosimetry. Med Phys 1996; 23:759-764.
44. Loudos G, Tsougos I, Boukis S, Karakatsanis N, Georgoulias P, Theodorou K, et al. A radionuclide dosimetry toolkit based on material specific Monte Carlo dose kernels. Nucl Med Commun 2009; 30:504-512.
45. Fischer DR. Assessments for high dose radionuclide therapy treatment planning. Radiat Protect Dosimetry 2003; 105:581-586.
46. ICRP. Radiation protection recommendations as applied to the disposal of long-lived solid radioactive waste. A report of The International Commission on Radiological Protection. Ann ICRP 1998; 28:i-vii. 1-25.
47. Fisher DR. Internal dosimetry for systemic radiation therapy semin. Radiat Oncol 2000; 10:123-132.
48. Tsougos I, Mavroidis P, Rajala J, Theodorou K, Jarvenpaa R, Pitkanen MA, et al. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol 2005; 50:3535-3554.
49. Tsougos I, Theodorou K, Rajala, J, Pitkänen MA, Holli K, Ojala AT, et al. Clinical validation of the LKB model and parameter sets for predicting radiation induced pneumonitis from breast cancer radiotherapy. Phys Med Biol 2006; 51:L1-L9.
50. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for 3-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991; 21:137-146.
51. Burman C, Kutcher GJ, Emami B. Fitting of normal tissue tolerance data to an analytical function. Int J Radiat Biol Phys 1991; 21:123-135.
52. Meredith RF, Buchsbaum DJ. Pretargeted radioimmunotherapy. Int J Radiat Oncol Biol Phys 2006; 66 (2 Suppl):S57-S59. Review.
53. Glatting G, Landmann M, Wunderlich A, Kull T, Mottaghy FM, Reske SN. Internal radionuclide therapy: software for treatment planning using tomographic data. Nuklearmedizin 2006; 45:269-272.